Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Gains from Investment Securities (2021 - 2023)

Historic Gains from Investment Securities for Biote (BTMD) over the last 3 years, with Q2 2023 value amounting to $11.8 million.

  • Biote's Gains from Investment Securities rose 44695.5% to $11.8 million in Q2 2023 from the same period last year, while for Dec 2023 it was $13.4 million, marking a year-over-year increase of 27933.04%. This contributed to the annual value of $13.4 million for FY2023, which is 36157.6% up from last year.
  • According to the latest figures from Q2 2023, Biote's Gains from Investment Securities is $11.8 million, which was up 44695.5% from $1.6 million recorded in Q1 2023.
  • In the past 5 years, Biote's Gains from Investment Securities registered a high of $11.8 million during Q2 2023, and its lowest value of -$13.8 million during Q2 2021.
  • Its 3-year average for Gains from Investment Securities is -$1.3 million, with a median of -$1.2 million in 2021.
  • In the last 5 years, Biote's Gains from Investment Securities plummeted by 27953.38% in 2022 and then skyrocketed by 44695.5% in 2023.
  • Over the past 3 years, Biote's Gains from Investment Securities (Quarter) stood at -$1.2 million in 2021, then soared by 52.69% to -$575000.0 in 2022, then skyrocketed by 2150.96% to $11.8 million in 2023.
  • Its Gains from Investment Securities was $11.8 million in Q2 2023, compared to $1.6 million in Q1 2023 and -$575000.0 in Q4 2022.